Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by LASIK Surgeons

Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) (www.bloomberg.com)
The Staar ICL is a lens for the correction of high amounts of nearsightedness and will never take over a significant amount of the Lasik market. Their growth in the market for the ICL is in spite of the decrease in Lasik nationwide because more surgeons have been trained in its placement and because...
Analysis of: A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema (www.ophsource.org)
This Phase III Clinical Trial clearly shows that focal grid laser is better than steroids in the management of Diabetic Macular Edema (DME).  This reaffirms laser as the current gold standard in the management of DME and casts doubts on numerous treatment modalities in the pipeline that use steroids...
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) (www.bloomberg.com)
The Visian ICL (Implantable Collamer Lens) is an exquisitely precise technology for the correction of high degrees of nearsightedness -- much higher than the reach of laser refractive surgery such as LASIK and PRK.  Given the price of the ICL and the intraocular surgey required for its...
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: Glaxo Seeks Guidance From Health Systems (online.wsj.com)
"He who pays the fiddler calls the tune."  Here's an example of the fiddler pro-actively asking the guy in the room with the deepest pocket what he'd like to hear.  If it's not something in the current repertoire, the fiddler seems willing to learn.  However, by the time he's got...
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma (www.nytimes.com)
I and many other ophthalmologists around the country use Avastin intravitreally for wet macular degeneration in doses far smaller than those used for systemic cancer.  Although it is an "off-label" use of the drug, the cost for using Avastin is 1/6oth of Lucentis, a very similar...
Analysis of: Most Doctors Aren’t Using Electronic Health Records (www.nytimes.com)
I HAD THE 2ND CHARTLESS OFFICE IN THE SOUTHEAST THE 1ST IN TN. WHEN I 1ST OPENED MY OFFICE IN NASHVILLE IN 1991. ONCE IN YOU CAN NEVER GO BACK TO CHARTS; HOWEVER, THE COST ARE HIGH AND THE LEARNING CURVE IS SLOW. MOST DOC'S DON'T LIKE A CHANGE. THUS THE CONVERSION RATE WILL BE HIGHER IN DOCS STARTING...
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA (www.cltoday.com)
This new lens represents a marriage of two important technologies in modern contact lens use; oxygen trasmissibility and convenience in wearing. This has the potential to become a significant portion of the contact lens market.
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA (www.cltoday.com)
Many patients who have irregular astigmatism will find a disposable silicone hydrogel lens to provide good vision with less irritation of the cornea due to protein build up in the lens.  This could be a big help to those who may not be LASIK candidates or who are awaiting future Custom LASIK surgery...
Analysis of: LASIK Worries? Some May See Better with Alternatives (www.washingtonpost.com)
Although the lask procedure as the primary method of keratorefractive surery has been under scrutiny recently it remains the mainstay of refractive surgery.  With a 95% approval it is difficult to critisize its effectiveness. However the 5% patient complaints must be addressed.  The risk of...
Analysis of: LASIK Worries? Some May See Better with Alternatives (www.washingtonpost.com)
The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years:  Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone.  About 1 out of 4 patients that consider lasik are actually good candidates...

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 124

Analytics


Generated at 2009-01-08T13:34:52.320